Senior VP of Business Development shares insight on industry and packaging trends.

Quotient Sciences and Intrepid Labs have announced a multi-year strategic partnership to advance the use of artificial intelligence (AI) in early drug development.

Trevi Therapeutics Inc., a clinical-stage biopharmaceutical company, has named David Hastings as Chief Financial Officer.

Neurimmune has expanded its transthyretin amyloid cardiomyopathy (ATTR-CM) collaboration with Alexion, an AstraZeneca company ...